Mannatech (NASDAQ:MTEX) Research Coverage Started at StockNews.com

Analysts at StockNews.com initiated coverage on shares of Mannatech (NASDAQ:MTEX) in a research report issued on Wednesday. The firm set a “buy” rating on the stock.

Mannatech Stock Performance

Shares of Mannatech stock opened at $8.33 on Wednesday. Mannatech has a one year low of $7.50 and a one year high of $15.10. The firm has a market capitalization of $15.67 million, a price-to-earnings ratio of -6.94 and a beta of 1.20. The business has a 50-day simple moving average of $8.64 and a 200 day simple moving average of $8.79. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.07 and a quick ratio of 0.51.

Mannatech (NASDAQ:MTEX) last issued its quarterly earnings data on Thursday, March 28th. The company reported ($0.94) EPS for the quarter. The company had revenue of $32.69 million for the quarter. Mannatech had a negative return on equity of 19.19% and a negative net margin of 1.70%.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.